Evidence map›Paper›PMID 25799137›Full record

Observational studyAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2015

Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.

Bradley A Warady, Alison G Abraham, George J Schwartz, Craig S Wong, Alvaro Muñoz, Aisha Betoko, Mark Mitsnefes, Frederick Kaskel, Larry A Greenbaum, Robert H Mak and 3 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00327860 (Chronic Kidney Disease in Children Prospective Cohort Study), which is not on this map. Cited by 149 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed, 2 pooled it
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00327860 recruitingnot on this map

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan2003 to 2028Enrolled1,300ConditionsChronic Kidney Disease
3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 2 syntheses or guidelines pooled it, 270 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Update on APOL1 and chronic kidney diseases in children.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  5. Treatment burden, healthcare experiences, and health-related quality of life among youth with chronic kidney disease treated for hypertension.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Hypertension: Evaluation and Management.Indian journal of pediatrics · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Untangling the Web of Dietary Micronutrient Intake and the Metabolome in Children with CKD.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  19. Article
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 1 country.

Bradley A WaradyDivision of Pediatric Nephrology, Children's Mercy Hospital, Kansas City, MO. Electronic address: bwarady@cmh.edu.
Alison G AbrahamJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
George J SchwartzUniversity of Rochester, Rochester, NY.
Craig S WongUniversity of New Mexico/Children's Hospital, Albuquerque, NM.
Alvaro MuñozJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Aisha BetokoJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Mark MitsnefesCincinnati Children's Hospital Medical Center, Cincinnati, OH.
Frederick KaskelChildren's Hospital at Montefiore, New York, NY.
Larry A GreenbaumEmory University and Children's Healthcare of Atlanta, Atlanta, GA.
Robert H MakUniversity of California at San Diego, La Jolla, CA.
Joseph FlynnSeattle Children's Hospital, Seattle, WA.
Marva M Moxey-MimsNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Susan FurthThe Children's Hospital of Philadelphia, Philadelphia, PA.
Johns Hopkins University · USChildren's Hospital at Montefiore · USChildren's Hospital of Philadelphia · USChildren's Mercy Hospital · USCincinnati Children's Hospital Medical Center · USEmory University · USNational Institutes of Health · USSeattle Children's Hospital · USUniversity of California, San Diego · USUniversity of Rochester · USUNM Children's Hospital · US

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI MEINZEN-DERR, JAREEN, STRAWN, JEFFREY ROBERT · 2015 to 2024
$37.5M
Chronic Kidney Disease in Children Study (C-Kid)U01DK066174 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SUSAN L. FURTH · 2003 to 2026
$25.1M
CKiD Cardiovascular Testing Travel SupplementU01DK066143 · NIDDK · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Bradley Alan Warady · 2003 to 2026
$24.2M
The Kidney Disease in Children Data Management and Analysis Center (KIDMAC)U01DK066116 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MUNOZ, ALVARO · 2003 to 2017
$17.9M
Central Biochemistry Laboratory of the CKiD ConsortiumU01DK082194 · NIDDK · UNIVERSITY OF ROCHESTER · PI SCHWARTZ, GEORGE J · 2008 to 2017
$3.5M
NCATS NIH HHS UL1 TR001425NIDDK NIH HHS U01 DK066116NIDDK NIH HHS U01 DK066143NIDDK NIH HHS U01 DK066174NIDDK NIH HHS U01 DK082194NIDDK NIH HHS U01DK-082194NIDDK NIH HHS U01-DK-66116NIDDK NIH HHS U01-DK-66143NIDDK NIH HHS U01-DK-66174
6 · The paper itself

Abstract

backgroundFew studies have prospectively evaluated the progression of chronic kidney disease (CKD) in children and adolescents, as well as factors associated with progression. STUDY

designProspective multicenter observational cohort study. SETTING &

participants496 children and adolescents with CKD enrolled in the Chronic Kidney Disease in Children (CKiD) Study. PREDICTORS: Proteinuria, hypoalbuminemia, blood pressure, dyslipidemia, and anemia. OUTCOMES: Parametric failure-time models were used to characterize adjusted associations between baseline levels and changes in predictors and time to a composite event of renal replacement therapy or 50% decline in glomerular filtration rate (GFR).

results398 patients had nonglomerular disease and 98 had glomerular disease; of these, 29% and 41%, respectively, progressed to the composite event after median follow-ups of 5.2 and 3.7 years, respectively. Demographic and clinical characteristics and outcomes differed substantially according to the underlying diagnosis; hence, risk factors for progression were assessed in stratified analyses, and formal interactions by diagnosis were performed. Among patients with nonglomerular disease and after adjusting for baseline GFR, times to the composite event were significantly shorter with urinary protein-creatinine ratio > 2mg/mg, hypoalbuminemia, elevated blood pressure, dyslipidemia, male sex, and anemia, by 79%, 69%, 38%, 40%, 38%, and 45%, respectively. Among patients with glomerular disease, urinary protein-creatinine ratio >2mg/mg, hypoalbuminemia, and elevated blood pressure were associated with significantly reduced times to the composite event by 94%, 71%, and 67%, respectively. Variables expressing change in patient clinical status over the initial year of the study contributed significantly to the model, which was cross-validated internally. LIMITATIONS: Small number of events in glomerular patients and use of internal cross-validation.

conclusionsCharacterization and modeling of risk factors for CKD progression can be used to predict the extent to which these factors, either alone or in combination, would shorten the time to renal replacement therapy or 50% decline in GFR in children with CKD.

Indexed as

AdolescentAnemiaChildChild, PreschoolCohort StudiesDisease ProgressionDyslipidemiasFemaleGlomerulonephritisHumansHypertensionHypoalbuminemiaInfantKidney Failure, ChronicMaleProspective Studiesadolescentschildrenchronic kidney disease (CKD)Chronic Kidney Disease in Children (CKiD) Studydisease progressiondisease trajectoryend-stage renal disease (ESRD)glomerular filtration rate (GFR)Pediatricproteinuriarenal replacement therapy (RRT)risk factorurinary protein-creatinine ratio (UPCR)

Identifiers

PMID25799137
PMCPMC4578873
OpenAlexW2005438826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.